Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor
- Martins, A.S.
- Mackintosh, C.
- Herrero Martín, D.
- Campos, M.
- Hernández, T.
- Ordóñez, J.-L.
- De Alava, E.
ISSN: 1078-0432
Datum der Publikation: 2006
Ausgabe: 12
Nummer: 11 I
Seiten: 3532-3540
Art: Artikel